SAT-170-A phenotypic resistance assay for clinical HCV isolates could help rationalise DAA therapy in individuals experiencing recurrent virologic failure
Authors:
- Christopher R. JonesCJChristopher R. Jones
- Ana Maria Ortega-PrietoAOAna Maria Ortega-Prieto
- Graham CookeGCGraham Cooke
- Marcus DornerMDMarcus Dorner
- 1 April 2019
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 70 (1) , e704